Resveratrol regulates PINK1/Parkin-mediated mitophagy via the lncRNA ZFAS1-miR-150-5p-PINK1 axis, and enhances the antitumor activity of paclitaxel against non-small cell lung cancer
Authors:
- 5 November 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 11 (6) , 962-974
Abstract
Non-small cell lung cancer (NSCLC) is a common malignant subtype of lung cancer with high mortality. Resveratrol (RSV) is a natural molecule that regulates mitochondrial metabolism. Here, we explored the effect of RSV on NSCLC cell mitophagy and paclitaxel (PTX) resistance. LncRNA ZFAS1, miR-150-5p, and PTEN-induced putative kinase 1 (PINK1) expressions in NSCLC cells were analyzed by RT-qPCR. Levels of PINK1, Parkin and autophagy related molecules LC3I and LC3II were assessed by western blot. Mitophagy was demonstrated by transmission electron microscopy. Luciferase reporter assay revealed that miR-150-5p directly interacted with ZFAS1 or PINK1. MTT was performed to test the IC50 of NSCLC cells. Cell proliferation and apoptosis were measured with CCK-8, EdU, and TUNEL assays. A549/PTX cells exhibited a higher mitophagy activity, and chemoresistance, whereas RSV suppressed PTX resistance and mitophagy in NSCLC cells. Furthermore, ZFAS1 was found to be a downstream effector of RSV in NSCLC cells. We next found ZFAS1 directly interacted with miR-150-5p and regulated the expression of a key mitophagy regulator PINK1. In addition, RSV modulated PTX resistance and mitophagy in NSCLC via ZFAS1/miR-150-5p/PINK1 axis. We validate that RSV influences mitophagy and PTX resistance in NSCLC via ZFAS1/miR-150-5p mediated PINK1/Parkin pathway. Combining these 2 drugs may be a new option of NSCLC therapy.Keywords
This publication has 44 references indexed in Scilit:
- Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPKOncoTargets and Therapy, 2018
- Emerging Targets in Advanced Non-Small-Cell Lung CancerFuture Oncology, 2018
- The biology and management of non-small cell lung cancerNature, 2018
- PINK1 Expression Is Associated with Poor Prognosis in Lung AdenocarcinomaThe Tohoku Journal of Experimental Medicine, 2018
- Staging of Non–Small-Cell Lung CancerPET Clinics, 2018
- High expression of PINK1 promotes proliferation and chemoresistance of NSCLCOncology Reports, 2017
- Role of Autophagy and Apoptosis in Non-Small-Cell Lung CancerInternational Journal of Molecular Sciences, 2017
- Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivoScientific Reports, 2016
- Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancerOncotarget, 2015
- Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular CarcinomaCancer Research, 2015